Versago Vascular Access, a spinoff of Primo Medical Group, designed and developed a new subcutaneous port to access the body's bloodstream and anatomical cavities that collect serous or ascitic fluid. The technology provides a large bore, reusable, power injectable conduit directly into a patient's bloodstream or other anatomical areas and in certain applications could potentially replace current technologies like ports, peripherally inserted central catheters (PICC) and central venous catheters (CVC) for a myriad of procedures.
Date | Amount | Type | Investors | Valuation |
---|---|---|---|---|
02/24/16 | $1,650,000 |
Primo Medical Group | undisclosed |